BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35130713)

  • 1. Abnormal photoplethysmography waveforms are associated with chemotherapy induced neuropathy.
    Bryce Y; Santos-Martin E; Ziv E; Gonzalez-Aguirre A; Moussa A; Friedman A; Maybody M
    Vasa; 2022 Mar; 51(2):85-92. PubMed ID: 35130713
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive Arterial Testing in Patients With Diabetes: A Guide for Foot and Ankle Surgeons.
    Wukich DK; Shen W; Raspovic KM; Suder NC; Baril DT; Avgerinos E
    Foot Ankle Int; 2015 Dec; 36(12):1391-9. PubMed ID: 26194106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
    Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
    Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients.
    Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D
    Clin Auton Res; 2022 Dec; 32(6):497-506. PubMed ID: 36129622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion Tensor Imaging of the Ankle as a Possible Predictor of Chemotherapy Induced Peripheral Neuropathy: Pilot Study.
    Gimber LH; Garland L; Krupinski EA; Chadaz TS; Schwenk M; Najafi B; Taljanovic MS
    Curr Probl Diagn Radiol; 2019; 48(2):121-126. PubMed ID: 29397266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised diagnostic accuracy study of a fully automated portable device for diagnosing peripheral arterial disease by measuring the toe-brachial index.
    Høyer C; Sandermann J; Petersen LJ
    Eur J Vasc Endovasc Surg; 2013 Jan; 45(1):57-64. PubMed ID: 23122184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoplethysmography and continuous-wave Doppler ultrasound as a complementary test to ankle-brachial index in detection of stenotic peripheral arterial disease.
    Ro du H; Moon HJ; Kim JH; Lee KM; Kim SJ; Lee DY
    Angiology; 2013 May; 64(4):314-20. PubMed ID: 23162005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease.
    AbuRahma AF; Adams E; AbuRahma J; Mata LA; Dean LS; Caron C; Sloan J
    J Vasc Surg; 2020 Mar; 71(3):937-945. PubMed ID: 31471230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Jin L; Zhang Y; Yang W
    Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort.
    Sreeram K; Seaton R; Greenwald MK; Kamgar M; Assad H; Baird T; Schwartz AG; Ruterbusch J; Simon MS
    Cancer Causes Control; 2023 May; 34(5):459-468. PubMed ID: 36934365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
    Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
    Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hide and seek: does the toe-brachial index allow for earlier recognition of peripheral arterial disease in diabetic patients?
    Stoekenbroek RM; Ubbink DT; Reekers JA; Koelemay MJ
    Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):192-8. PubMed ID: 25516530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced Peripheral Neuropathy Among Paediatric Oncology Patients.
    Purser MJ; Johnston DL; McMillan HJ
    Can J Neurol Sci; 2014 Jul; 41(4):442-7. PubMed ID: 24878467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
    Bulls HW; Hoogland AI; Kennedy B; James BW; Arboleda BL; Apte S; Chon HS; Small BJ; Gonzalez BD; Jim HSL
    Gynecol Oncol; 2019 Feb; 152(2):310-315. PubMed ID: 30558975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.
    Lee KM; Jung D; Hwang H; Son KL; Kim TY; Im SA; Lee KH; Hahm BJ
    J Psychosom Res; 2018 May; 108():14-19. PubMed ID: 29602320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trial.
    Lemanska A; Harkin A; Iveson T; Kelly C; Saunders M; Faithfull S
    ESMO Open; 2023 Dec; 8(6):102063. PubMed ID: 37988949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.